RE: Trial vs Settlement22 Aug 2022 19:35
I believe that I no understand why insufficiency was not addressed during the IPR. Apparently, inter partes review can only address prior art issues.
https://fishpostgrant.com/inter-partes-review/
"Inter partes review became available on September 16, 2012, as a procedure to challenge the validity of patent claims based on patents and printed publications. Inter partes review can be initiated immediately following issuance (or reissuance) of patents examined under the first to invent rules (i.e., patents filed prior to March 16, 2013), since post-grant review is not available for these patents. "
Post-Grant Review must be done within one year of the granting of the patent. Samsung scientist's emails to Nanoco requesting help might have been part of a sinister plot to claim insufficiency. I can not imagine that Mintz would not be able to refute Samsung's claim of insufficiency. Hopefully, they can present a video illustrating how a POSITA can use the patent to manufacture QD's. It can't be too difficult if a toilet paper company can produce CFQD's.